CL2008000191A1 - Compuestos derivados de 4-amino-cinnotina-3-carboxamida; inhibidores de csf-1r quinasa; su proceso de preparacion; y su uso para tratar el cancer. - Google Patents

Compuestos derivados de 4-amino-cinnotina-3-carboxamida; inhibidores de csf-1r quinasa; su proceso de preparacion; y su uso para tratar el cancer.

Info

Publication number: CL2008000191A1
Authority: CL; Chile
Prior art keywords: cinnotina; carboxamida; csf; amino; preparation process
Prior art date: 2007-01-25

Application number

CL200800191A

Other languages

English (en)

Inventor

Leslie Dakin

Claude A Ogoe

David Scott

Xiaolan Zhend

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-01-25

Filing date

2008-01-23

Publication date

2008-08-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39310013&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008000191(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-01-23 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2008-08-22 Publication of CL2008000191A1 publication Critical patent/CL2008000191A1/es

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

CL200800191A 2007-01-25 2008-01-23 Compuestos derivados de 4-amino-cinnotina-3-carboxamida; inhibidores de csf-1r quinasa; su proceso de preparacion; y su uso para tratar el cancer. CL2008000191A1 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US88658507P	2007-01-25	2007-01-25
US95157607P	2007-07-24	2007-07-24

Publications (1)

Publication Number	Publication Date
CL2008000191A1 true CL2008000191A1 (es)	2008-08-22

Family

ID=39310013

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL200800191A CL2008000191A1 (es)	2007-01-25	2008-01-23	Compuestos derivados de 4-amino-cinnotina-3-carboxamida; inhibidores de csf-1r quinasa; su proceso de preparacion; y su uso para tratar el cancer.

Country Status (18)

Country	Link
US (2)	US7723337B2 (es)
EP (1)	EP2118072A1 (es)
JP (1)	JP2010500988A (es)
KR (1)	KR20090111337A (es)
AR (1)	AR065042A1 (es)
AU (1)	AU2008208751A1 (es)
BR (1)	BRPI0808005A2 (es)
CA (1)	CA2675621A1 (es)
CL (1)	CL2008000191A1 (es)
CO (1)	CO6190614A2 (es)
EC (1)	ECSP099539A (es)
IL (1)	IL199911A0 (es)
MX (1)	MX2009007889A (es)
PE (1)	PE20081693A1 (es)
RU (1)	RU2009131834A (es)
TW (1)	TW200843775A (es)
UY (1)	UY30880A1 (es)
WO (1)	WO2008090353A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7465795B2 (en) *	2005-12-20	2008-12-16	Astrazeneca Ab	Compounds and uses thereof
TW200829555A (en) *	2006-11-10	2008-07-16	Astrazeneca Ab	Chemical compounds
CN102089286A (zh) *	2008-05-07	2011-06-08	阿斯利康(瑞典)有限公司	化合物
CA2837199A1 (en) *	2011-05-23	2012-11-29	Elan Pharmaceuticals, Inc.	Cinnoline compounds as inhibitor of lrrk2 kinase activity
US9365566B2 (en)	2012-03-27	2016-06-14	Takeda Pharmaceutical Company Limited	Cinnoline derivatives
GB201516504D0 (en)	2015-09-17	2015-11-04	Astrazeneca Ab	Imadazo(4,5-c)quinolin-2-one Compounds and their use in treating cancer
KR20180127419A (ko) *	2016-03-21	2018-11-28	아스트라제네카 아베	신놀린-4-아민 화합물 및 암을 치료하는 이의 용도

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8621425D0 (en)	1986-09-05	1986-10-15	Smith Kline French Lab	Compounds
DK273689A (da)	1988-06-06	1989-12-07	Sanofi Sa	4-amino-3-carboxyquinoliner og -naphthyridiner, fremgangsmaade til deres fremstilling og anvendelse deraf i laegemidler
EP0480052B1 (en)	1990-03-28	1998-01-14	Otsuka Pharmaceutical Co., Ltd.	Quinoline derivative, antiulcer drug containing the same, and production of said derivative
UA58494C2 (uk)	1995-06-07	2003-08-15	Зенека Лімітед	Похідні n-гетероарилпіридинсульфонаміду, фармацевтична композиція, спосіб одержання та спосіб протидії впливам ендотеліну
GB9624482D0 (en)	1995-12-18	1997-01-15	Zeneca Phaema S A	Chemical compounds
US6184225B1 (en)	1996-02-13	2001-02-06	Zeneca Limited	Quinazoline derivatives as VEGF inhibitors
DE69709319T2 (de)	1996-03-05	2002-08-14	Astrazeneca Ab	4-anilinochinazolin derivate
GB9718972D0 (en)	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
GB9714249D0 (en)	1997-07-08	1997-09-10	Angiogene Pharm Ltd	Vascular damaging agents
GB9900334D0 (en)	1999-01-07	1999-02-24	Angiogene Pharm Ltd	Tricylic vascular damaging agents
GB9900752D0 (en)	1999-01-15	1999-03-03	Angiogene Pharm Ltd	Benzimidazole vascular damaging agents
JP2003535078A (ja)	2000-05-31	2003-11-25	アストラゼネカアクチボラグ	血管損傷活性のあるインドール誘導体
BR0112224A (pt)	2000-07-07	2003-06-10	Angiogene Pharm Ltd	Composto, composição farmacêutica, uso de um composto ou de um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo, e, processo para preparar um composto
EP1301498A1 (en)	2000-07-07	2003-04-16	Angiogene Pharmaceuticals Limited	Colchinol derivatives as angiogenesis inhibitors
SE0101675D0 (sv)	2001-05-11	2001-05-11	Astrazeneca Ab	Novel composition
GB0322726D0 (en)	2003-09-27	2003-10-29	Glaxo Group Ltd	Compounds
WO2006067445A2 (en)	2004-12-22	2006-06-29	Astrazeneca Ab	Csf-1r kinase inhibitors
US20060264439A1 (en)	2005-05-17	2006-11-23	Supergen, Inc.	Inhibitors of polo-like kinase-1
GB0521563D0 (en)	2005-10-21	2005-11-30	Glaxo Group Ltd	Novel compounds
CN101466682A (zh)	2006-04-14	2009-06-24	阿斯利康(瑞典)有限公司	作为csf-1r激酶抑制剂的4-苯胺基喹啉-3-甲酰胺
TW200829555A (en)	2006-11-10	2008-07-16	Astrazeneca Ab	Chemical compounds

2008
- 2008-01-23 CL CL200800191A patent/CL2008000191A1/es unknown
- 2008-01-24 UY UY30880A patent/UY30880A1/es unknown
- 2008-01-24 RU RU2009131834/04A patent/RU2009131834A/ru not_active Application Discontinuation
- 2008-01-24 KR KR1020097017221A patent/KR20090111337A/ko not_active Application Discontinuation
- 2008-01-24 MX MX2009007889A patent/MX2009007889A/es not_active Application Discontinuation
- 2008-01-24 EP EP08701929A patent/EP2118072A1/en not_active Withdrawn
- 2008-01-24 WO PCT/GB2008/000256 patent/WO2008090353A1/en active Application Filing
- 2008-01-24 BR BRPI0808005-4A patent/BRPI0808005A2/pt not_active IP Right Cessation
- 2008-01-24 JP JP2009524240A patent/JP2010500988A/ja active Pending
- 2008-01-24 AU AU2008208751A patent/AU2008208751A1/en not_active Abandoned
- 2008-01-24 CA CA002675621A patent/CA2675621A1/en not_active Abandoned
- 2008-01-24 TW TW097102685A patent/TW200843775A/zh unknown
- 2008-01-24 PE PE2008000185A patent/PE20081693A1/es not_active Application Discontinuation
- 2008-01-25 AR ARP080100319A patent/AR065042A1/es not_active Application Discontinuation
- 2008-09-15 US US12/210,588 patent/US7723337B2/en not_active Expired - Fee Related
2009
- 2009-07-16 IL IL199911A patent/IL199911A0/en unknown
- 2009-07-23 EC EC2009009539A patent/ECSP099539A/es unknown
- 2009-07-24 CO CO09077326A patent/CO6190614A2/es not_active Application Discontinuation
2010
- 2010-05-17 US US12/781,277 patent/US20110098283A1/en not_active Abandoned

Also Published As

Publication number	Publication date
RU2009131834A (ru)	2011-02-27
UY30880A1 (es)	2008-09-02
IL199911A0 (en)	2010-04-15
MX2009007889A (es)	2009-07-31
CA2675621A1 (en)	2008-07-31
US20090012084A1 (en)	2009-01-08
JP2010500988A (ja)	2010-01-14
PE20081693A1 (es)	2009-01-18
EP2118072A1 (en)	2009-11-18
TW200843775A (en)	2008-11-16
ECSP099539A (es)	2009-08-28
CO6190614A2 (es)	2010-08-19
WO2008090353A1 (en)	2008-07-31
US7723337B2 (en)	2010-05-25
US20110098283A1 (en)	2011-04-28
AU2008208751A1 (en)	2008-07-31
BRPI0808005A2 (pt)	2013-07-30
KR20090111337A (ko)	2009-10-26
AR065042A1 (es)	2009-05-13

Publication	Publication Date	Title
BRPI0821688A2 (pt)	2016-08-30	mistura para o tratamento de fertilizantes contendo uréia
DK3289876T3 (da)	2022-10-10	Forbindelser til behandling af cancer
DK2195015T3 (da)	2017-06-19	Sammensætning til behandling af prostatacancer
BRPI0908100A2 (pt)	2015-10-06	produto combinação, uso de um composto, e, método de tratar câncer
CR11019A (es)	2009-10-20	3-imidazolil-indoles para el tratamiento de enfermedades proliferativas
BRPI0810076A2 (pt)	2014-10-21	Processo para preparar compostos, uso de compostos, composto, e mistura.
BRPI0818426A2 (pt)	2017-06-13	produto de combinação, uso de um produto de combinação, e, método para tratar câncer
CL2007003849A1 (es)	2008-07-04	Compuestos derivados de nafto[c]pirrol sustituidos con aminoacidos, utiles para tratar el cancer.
BRPI0807487A2 (pt)	2015-09-01	Uso de antagonistas de il-23 para o tratamento de infecção
BRPI0908428A2 (pt)	2015-12-08	uso de ranozalina para tratar a dor.
BRPI1010937A2 (pt)	2019-09-24	composto, uso de um composto, e, método para tratar câncer
BRPI0811635A2 (pt)	2014-11-11	Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos
DK2478907T3 (da)	2021-05-25	Sammensætninger til behandling af kræft
CL2008000403A1 (es)	2008-08-18	Compuestos derivados de pentafluorotiobenzamido-acetonitrilo; composicion farmaceutica; y uso para tratar una infestacion por parasitos.
ES2397671T8 (es)	2013-05-23	Procedimiento para preparar voriconazol
BRPI0919238A2 (pt)	2019-09-24	métodos e composições para o tratamento de câncer
BRPI1013618A2 (pt)	2016-04-19	pirimidinas substituídas para o tratamento de câncer
BRPI0813670A2 (pt)	2014-12-30	Compostos para tratamento
BRPI1007995A2 (pt)	2019-09-24	orto-aminoamidas para o tratamento de cãncer.
CL2008000029A1 (es)	2008-04-04	Compuestos derivados de 1-bencil imidazol, inhibidores de eg-5; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer.
BRPI0922884A2 (pt)	2018-11-06	compostos para tratamento de câncer
BRPI1010874A2 (pt)	2017-05-30	composição para o tratamento de câncer de próstata
BRPI0909016A2 (pt)	2015-12-22	anticorpos úteis para o tratamento do câncer
BRPI0915439A2 (pt)	2015-11-10	composição tópica para o tratamento de ceratose actínica
BRPI0818170A2 (pt)	2017-05-16	5-cianotienopiridinas para o tratamento de tumores.